Peptisource

Retatrutid 20mg

Retatrutid is a novel peptide-based drug belonging to the class of triple receptor agonists targeting GLP-1R/GIPR/GCGR, composed of 39 amino acids. Its design is inspired by endogenous intestinal insulin-like hormones (such as GIP) and, through structural optimization, it can simultaneously activate the GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and glucagon receptor (GCGR). Activating GLP-1R promotes insulin secretion, inhibits glucagon release, lowers blood glucose levels, delays gastric emptying, and reduces appetite; activating GIPR enhances insulin secretion effects, further lowers blood glucose levels, and also plays a role in lipid metabolism; activating GCGR promotes energy expenditure, enhances hepatic gluconeogenesis inhibition, and reduces hepatic fat deposition.

Spec: 20mg
Packaging: 1kits（10Vials）
$320USD
1

▎What is Retatrutid?


Retatrutid is a novel peptide-based drug belonging to the class of triple receptor agonists targeting GLP-1R/GIPR/GCGR, composed of 39 amino acids. Its design is inspired by endogenous intestinal insulin-like hormones (such as GIP) and, through structural optimization, it can simultaneously activate the GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and glucagon receptor (GCGR). Activating GLP-1R promotes insulin secretion, inhibits glucagon release, lowers blood glucose levels, delays gastric emptying, and reduces appetite; activating GIPR enhances insulin secretion effects, further lowers blood glucose levels, and also plays a role in lipid metabolism; activating GCGR promotes energy expenditure, enhances hepatic gluconeogenesis inhibition, and reduces hepatic fat deposition.